That was a surprise for me, to think that we could be finished phase 1(a?) of Checkvacc by the end year successfully. Cohort 4 may be enough for OBD, even possibly cohort 3. I doubt it will take a significant amount of time to publish final data as we aren't waiting on OS like we were with Hervaxx. That is really exciting, the first successful validation of a cf33 trial. That will somewhat de-risk by association Vaxxinia and OnCarLytics. We should have a really solid year. I hope some of this stuff as announced and published before IMUOC's in Nov.
Media Thread, page-6316
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |